Contract Staffing
Customized Contract Staffing for your Every Study, Every Project, Every Time
Find top talent with Zenovel's GCP staffing services. From research to production, we provide tailored solutions to meet your pharmaceutical staffing needs.
Zenovel provides flexible contract staffing and recruiting options for global CROs and pharmaceutical firms, offering Full-Time Equivalent (FTE) models with experienced CRAs and Auditors from over 30 countries. These models enable customized staffing solutions for specific time periods and requirements related to studies or assignments. Zenovel provides flexibility of 0.5 FTE to 1 FTE for a specific time duration (e.g., 3 months) and for a specific study or assignment.
FTE is offered for various roles including CRA, CTA, CRC, Project Manager, Data Management, Medical & Scientific Writing, Biometrics, and more.
Contact us today to learn more about how Zenovel’s flexible staffing services can meet your staffing needs effectively and efficiently.
At Zenovel, our contract staffing solutions are designed to seamlessly integrate with your broader quality and compliance framework, supporting sponsors and CROs across all stages of clinical research operations. Our experienced professionals work in alignment with Zenovel’s GCP compliance and oversight services to ensure consistency, accountability, and regulatory readiness, while adhering to global expectations outlined by regulatory authorities such as the FDA and ICH-GCP guidelines. This integrated approach enables organizations to scale resources efficiently without compromising data integrity, inspection preparedness, or study quality.
People Also Ask (FAQs)
Contract staffing refers to hiring skilled professionals on a temporary or project-based basis to support clinical research and pharmaceutical operations. This approach allows companies to quickly access specialized talent for clinical trials, regulatory projects, or quality assurance activities without long-term hiring commitments.
Contract staffing services can provide experienced professionals such as Clinical Research Associates (CRAs), Clinical Trial Assistants (CTAs), Clinical Research Coordinators (CRCs), project managers, data managers, medical writers, biometrics experts, and quality assurance professionals to support different stages of clinical research.
The Full-Time Equivalent (FTE) model allows organizations to hire experienced professionals for a specific percentage of time, such as 0.5 FTE or 1 FTE, for a defined project or study duration. This flexible staffing model helps pharmaceutical companies manage workload and optimize operational costs during clinical trials.
Pharmaceutical companies use contract staffing to quickly fill resource gaps, access specialized expertise, and manage fluctuating project workloads. Contract staffing helps organizations maintain efficiency, meet regulatory requirements, and ensure smooth execution of clinical studies without long-term employment commitments.
Zenovel provides flexible contract staffing solutions for global CROs and pharmaceutical companies by offering experienced clinical research professionals across multiple roles. Their staffing services help organizations scale teams quickly, maintain regulatory compliance, and support successful clinical trial execution.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
